EUVIMEDEUVIMED entdecken
Crossref

Duration of Pregnancy Prolongation with Atosiban in Twin Pregnancies Diagnosed with Threatened Preterm Labor

Nguyen Thi Yen, Ho Minh Tuan, Nguyen Thi Cam Nhung, Nguyen Hong Hoa

Science & Technology Development Journal - Health Sciences · 2025

DOI: 10.32508/stdjhs.v6i2.676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science & Technology Development Journal - Health Sciences, 2025. Verfasst von Nguyen Thi Yen und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Twin pregnancy is a high-risk condition associated with numerous maternal and fetal complications. Common complications include hypertensive disorders, preterm birth, congenital abnormalities, and those specific to twin gestations. Among these, preterm birth is the most prevalent, with a rate exceeding 50% in twin pregnancies, 10.8 times higher than in singleton pregnancies. Preterm birth not only leads to significant neonatal morbidity and mortality but also imposes a substantial economic burden for neonatal care. Approximately 70% of preterm infant deaths occur in the neonatal period, and 50% of these children die within the first five years of life. The cornerstone of managing threatened preterm labor focuses on preventing or inhibiting uterine contractions, thereby prolonging pregnancy to allow for the administration of corticosteroids for fetal lung maturation, magnesium sulfate for fetal neuroprotection, and transfer to a tertiary care center. Atosiban is a highly effective tocolytic agent with minimal maternal and fetal side effects.

Methods

This was a retrospective case series study of 81 pregnant women with twin gestations diagnosed with threatened preterm labor, who were treated with Atosiban at Tu Du Hospital.

Results

The mean pregnancy prolongation was 120 hours. The rate of pregnancy prolongation for ≥ 48 hours was 88.9%. The incidence of adverse effects from Atosiban was low (2.5%).

Conclusion

Atosiban is a highly effective and well-tolerated tocolytic agent for the management of threatened preterm labor in women with twin pregnancies.

Zitieren

APA

Yen, N. T., Tuan, H. M., Nhung, N. T. C., & Hoa, N. H. (2025). Duration of Pregnancy Prolongation with Atosiban in Twin Pregnancies Diagnosed with Threatened Preterm Labor. Science & Technology Development Journal - Health Sciences. https://doi.org/10.32508/stdjhs.v6i2.676

Vancouver

Yen NT, Tuan HM, Nhung NTC, Hoa NH. Duration of Pregnancy Prolongation with Atosiban in Twin Pregnancies Diagnosed with Threatened Preterm Labor. Science & Technology Development Journal - Health Sciences. 2025. doi:10.32508/stdjhs.v6i2.676

BibTeX
@article{Yen2025,
  author = {Yen, Nguyen Thi and Tuan, Ho Minh and Nhung, Nguyen Thi Cam and Hoa, Nguyen Hong},
  title = {Duration of Pregnancy Prolongation with Atosiban in Twin Pregnancies Diagnosed with Threatened Preterm Labor},
  journal = {Science & Technology Development Journal - Health Sciences},
  year = {2025},
  doi = {10.32508/stdjhs.v6i2.676}
}
Kostenlos starten →